Booster shots
The news in August that Moderna’s next-gen COVID-19 booster had become the first authorized Omicron-specific bivalent vaccine was shared widely on social media platforms.
The UK’s regulatory agency gave the green light to Moderna’s Spikevax Bivalent Original/Omicron booster shot that month, for use in individuals over 18 years of age.
“The first generation of COVID-19 vaccines being used in the UK continue to provide important protection against the disease and save lives. What this bivalent vaccine gives us is a sharpened tool in our armoury to help protect us against this disease as the virus continues to evolve,” commented Dr June Raine, MHRA chief executive, at the time.
Photo credit: GettyImages/Morsa Images